Extrawell Pharmaceutical Holdings Limited (0858.HK)
HKD 0.05
(2.04%)
HKD 0.05
(2.04%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 59.09 Million | 72.57 Million | 73.92 Million | 78.8 Million | 77.58 Million | 89.21 Million |
| Cost of Revenue | 30.31 Million | 41.43 Million | 36.36 Million | 36.23 Million | 34.66 Million | 39.61 Million |
| Gross Profit | 28.77 Million | 31.14 Million | 37.55 Million | 42.56 Million | 42.91 Million | 49.6 Million |
| Operating Expenses | 35.52 Million | 42.29 Million | 56.01 Million | 49.55 Million | 59.24 Million | 11.64 Million |
| Selling, General and Administrative Expenses | 35.33 Million | 41.41 Million | 55.57 Million | 49.55 Million | 59.24 Million | 66.57 Million |
| Research and Development Expenses | 194 Thousand | 881 Thousand | 444 Thousand | - | - | - |
| Other Expenses | - | 437 Thousand | 209 Thousand | - | 2000.00 | - |
| Cost and Expenses | 65.84 Million | 83.73 Million | 92.38 Million | 85.78 Million | 93.91 Million | 51.25 Million |
| Operating Income | -8.16 Million | -11.15 Million | -18.45 Million | -6.98 Million | -16.33 Million | -16.97 Million |
| Interest Expense | 18.8 Million | 15.63 Million | 13.22 Million | 11.24 Million | 9.34 Million | 7.82 Million |
| Income Tax Expense | 2.13 Million | 1.12 Million | 1.23 Million | 4.31 Million | -90 Thousand | 50 Thousand |
| Earnings before Tax | -159.5 Million | 134.75 Million | 135.98 Million | -116.78 Million | 85.49 Million | 63.37 Million |
| Net Income | -162.94 Million | 129.26 Million | 130.58 Million | -121.09 Million | 83.28 Million | 64.03 Million |
| Earnings Per Share Basic | -0.07 | 0.05 | 0.05 | -0.05 | 0.03 | 0.02 |
| Earnings Per Share Diluted | -0.07 | 0.04 | 0.04 | -0.05 | 0.03 | 0.02 |
| Weighted Average Shares Outstanding | 2.39 Billion | 2.39 Billion | 2.39 Billion | 2.39 Billion | 2.39 Billion | 3.29 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.39 Billion | 3.29 Billion | 3.29 Billion | 2.39 Billion | 3.29 Billion | 3.29 Billion |
| Gross Margin | 0.49 | 0.43 | 0.51 | 0.54 | 0.55 | 0.56 |
| EBIT Margin | -2.19 | -0.03 | -0.13 | 0.01 | -0.13 | -0.12 |
| Profit Margin | -2.76 | 1.78 | 1.77 | -1.54 | 1.07 | 0.72 |
| EBITDA | -129.51 Million | 159.05 Million | 157.84 Million | -97.47 Million | 101.14 Million | 77.43 Million |
| Earnings Before Tax Margin | -0.14 | -0.15 | -0.25 | -0.09 | -0.21 | -0.19 |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 59.09 Million | 28.95 Million | 30.14 Million | 72.57 Million | 38.48 Million | 34.09 Million |
| Cost of Revenue | 30.31 Million | 15.06 Million | 15.25 Million | 41.43 Million | 20.87 Million | 20.56 Million |
| Gross Profit | 28.77 Million | 13.88 Million | 14.89 Million | 31.14 Million | 17.61 Million | 13.53 Million |
| Operating Expenses | 36.94 Million | 17.35 Million | 18.21 Million | 42.29 Million | 20.73 Million | 21.56 Million |
| Selling, General and Administrative Expenses | - | 17.15 Million | 18.21 Million | - | 20.73 Million | 21.56 Million |
| Research and Development Expenses | - | 194 Thousand | - | - | 881 Thousand | - |
| Other Expenses | 414 Thousand | - | - | 437 Thousand | - | - |
| Cost and Expenses | 67.26 Million | 32.42 Million | 33.46 Million | 83.73 Million | 41.6 Million | 42.12 Million |
| Operating Income | -8.16 Million | -3.46 Million | -3.32 Million | -11.15 Million | -3.12 Million | -8.03 Million |
| Interest Expense | 18.8 Million | 9.78 Million | 9.01 Million | 15.63 Million | 8.13 Million | 7.49 Million |
| Income Tax Expense | 2.13 Million | 1.01 Million | 1.11 Million | 1.12 Million | 920 Thousand | 208 Thousand |
| Earnings before Tax | -157.23 Million | 76.28 Million | -235.24 Million | 134.75 Million | 87.47 Million | 47.27 Million |
| Net Income | -162.94 Million | 74.77 Million | -237.72 Million | 129.26 Million | 83.44 Million | 45.82 Million |
| Earnings Per Share Basic | - | 0.03 | -0.10 | - | 0.03 | 0.02 |
| Earnings Per Share Diluted | - | 0.03 | -0.10 | - | 0.03 | 0.01 |
| Weighted Average Shares Outstanding | 2.39 Billion | 2.39 Billion | 2.39 Billion | 2.39 Billion | 2.39 Billion | 2.39 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.39 Billion | 2.39 Billion | 2.39 Billion | 3.29 Billion | 3.29 Billion | 3.29 Billion |
| Gross Margin | 0.49 | 0.48 | 0.49 | 0.43 | 0.46 | 0.40 |
| EBIT Margin | - | 0.01 | 0.04 | - | 0.04 | -0.11 |
| Profit Margin | -2.76 | 2.58 | -7.89 | 1.78 | 2.17 | 1.34 |
| EBITDA | - | 395 Thousand | 1.12 Million | - | 1.38 Million | -3.87 Million |
| Earnings Before Tax Margin | -0.14 | -0.12 | -0.11 | -0.15 | -0.08 | -0.24 |
ROBU
UFI
SWG
PROC
2201
DCOHF